Dabigatran Users With Non-Valvular Atrial Fibrillation in the Us: A Characterization of Dabigatran Initiators and Switchers

Value Health. 2014 Nov;17(7):A499. doi: 10.1016/j.jval.2014.08.1498. Epub 2014 Oct 26.

Authors

D Shash¹, J Schnee², G Schneider³, N Schoof¹, K Zint¹, A Clemens⁴, D B Bartels¹

Affiliations

¹ Boehringer Ingelheim GmbH, Ingelheim, Germany.
² Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.
³ Evidera, Lexington, MA, USA.
⁴ University Medical Center Mainz, Mainz, Germany.

PMID: 27201505
DOI: 10.1016/j.jval.2014.08.1498

No abstract available